Biologic medicines are revolutionizing the way we treat diseases. We are working to expand access to these medicines for patients globally. Kashiv’s capabilities span mABs, microbials, bi-specifics, fusion proteins, and more.
505(b)(2)
We are committed to patient-centered innovation, using our robust development capabilities to improve known medicines.
Generic Complex Peptides
Peptide-based medicines are very similar to biologic medicines. We aim to expand access to important medicines regardless of regulatory pathway.
About us
Who We Are
We are a diverse team brought together by a shared purpose.
With state-of-the-art facilities in the US and India, we are equipped to develop and manufacture biologics at the highest quality standards.
600
+
Employees
Of which over half hold advanced degrees
Our Approach
We believe that a vertically integrated approach, from R&D through fill and finish manufacturing, gives us the focus, scale and speed needed to achieve our mission.
